Skip to main content
OpenTrials

Clinical trial condition

Type 2 Diabetes Mellitus

Explore clinical trials studying Type 2 Diabetes Mellitus. Study availability and eligibility vary by location and protocol.

1,509 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Type 2 Diabetes Mellitus trial results

Completed

Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin

NCT01596504

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 276008 Berlin, Germany
  • Investigational Site Number 276006 Berlin, Germany
  • Investigational Site Number 276004 Kiel, Germany
  • Investigational Site Number 276002 Mainz, Germany
View Trial Details
Completed

Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin

NCT01517412

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 840112 Glendale, Arizona, United States
  • Investigational Site Number 840113 Mesa, Arizona, United States
  • Investigational Site Number 840105 Phoenix, Arizona, United States
  • Investigational Site Number 840102 Tempe, Arizona, United States
View all 82 locations
View Trial Details
Completed

Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin

NCT01169779

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 156011 Beijing, China
  • Investigational Site Number 156012 Beijing, China
  • Investigational Site Number 156019 Beijing, China
  • Investigational Site Number 156002 Beijing, China
View all 35 locations
View Trial Details
Completed

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

NCT00975286

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Sanofi-Aventis Investigational Site Number 840223 Mesa, Arizona, United States
  • Sanofi-Aventis Investigational Site Number 840206 Hot Springs, Arkansas, United States
  • Sanofi-Aventis Investigational Site Number 840201 Little Rock, Arkansas, United States
  • Sanofi-Aventis Investigational Site Number 840212 Mountain Home, Arkansas, United States
View all 140 locations
View Trial Details
Completed

24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years

NCT00976937

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Sanofi-Aventis Investigational Site Number 840019 Montgomery, Alabama, United States
  • Sanofi-Aventis Investigational Site Number 840003 Muscle Shoals, Alabama, United States
  • Sanofi-Aventis Investigational Site Number 840022 Mesa, Arizona, United States
  • Sanofi-Aventis Investigational Site Number 840011 Anaheim, California, United States
View all 92 locations
View Trial Details
Completed

Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine

NCT02200991

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 392-107 Atsugi-shi, Japan
  • Investigational Site Number 392-125 Chiyoda-ku, Japan
  • Investigational Site Number 392-121 Chuoh-ku, Japan
  • Investigational Site Number 392-102 Ichihara-shi, Japan
View all 20 locations
View Trial Details

Related conditions